Meeting
2023 ASCO Annual Meeting
Germline mutations in hereditary renal cell carcinoma (RCC) genes among 32,240 patients with all cancer types.
Authors
Maria Isabel Carlo
Memorial Sloan Kettering Cancer Center, New York, NY
Maria Isabel Carlo , Andrew Schroeder , Semanti Mukherjee , Yelena Kemel , Ritesh R Kotecha , Chung-Han Lee , Neil J. Shah , Darren R. Feldman , Ying L Liu , Michael Francis Walsh , Alicia Latham , Martin H Voss , Ying-Bei Chen , Zsofia Kinga Stadler , Diana Mandelker , Kenneth Offit , Robert J. Motzer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4559)
DOI
10.1200/JCO.2023.41.16_suppl.4559
Abstract #
4559
Poster Bd #
51
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Impact of cancer susceptibility gene (CSG) mutations in advanced NSCLC (aNSCLC).
First Author: Danielle Klingberg
Poster
2020 Genitourinary Cancers Symposium
Prevalence of pathogenic germline risk variants (PVs) in 1829 renal cell carcinoma (RCC) patients (pts).
First Author: Sarah Abou Alaiwi
Poster
2021 ASCO Annual Meeting
Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types.
First Author: Kristen Hanson
Poster
2021 Genitourinary Cancers Symposium
Evaluation of germline genetic testing criteria in early-onset kidney cancer.
First Author: Hong Truong